Psyence Biomedical Ltd. Warrant (PBMWW)
USD 0.01
(1.57%)
USD 0.01
(1.57%)
| Breakdown | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating Cash Flow | -2.94 Million | -1.59 Million | -1.39 Million |
| Net Income | -51.15 Million | -3.2 Million | -1.85 Million |
| Depreciation & Amortization | 240.00 | - | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 317.88 Thousand | 221.28 Thousand | 332.06 Thousand |
| Change in working capital | -1.17 Million | 1.47 Million | 129.74 Thousand |
| Other non-cash items | 43.58 Million | - | - |
| Investing Cash Flow | -5727.00 | - | -32.03 Thousand |
| Investments in PPE | -5727.00 | - | - |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | -32.03 Thousand |
| Financing Cash Flow | 2.35 Million | 1.17 Million | -1.62 Million |
| Debt repayment | -2.35 Million | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | - | - |
| Other Financing Activities | - | 1.17 Million | -1.62 Million |
| Accounts receivables | 107.62 Thousand | - | - |
| Accounts payables | - | - | - |
| Inventory | - | - | - |
| Other working capital | -1.28 Million | - | - |
| Cash at beginning of period | 1.33 Million | 1.75 Million | 4.81 Million |
| Cash at end of period | 733.18 Thousand | 1.33 Million | 1.75 Million |
| Capital Expenditure | -5727.00 | - | - |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -601.09 Thousand | -419.15 Thousand | -3.05 Million |
| Free Cash Flow | -2.95 Million | -1.59 Million | -1.39 Million |
| Breakdown | 2023 FY | 2022 FY | 2021 FY |
|---|---|---|---|
| Operating Cash Flow | - | - | - |
| Net Income | -51.15 Million | -3.2 Million | -1.85 Million |
| Depreciation & Amortization | 240.00 | - | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 317.88 Thousand | 221.28 Thousand | 332.06 Thousand |
| Change in working capital | -1.17 Million | 1.47 Million | 129.74 Thousand |
| Other non-cash items | 43.58 Million | - | - |
| Investing Cash Flow | -5727.00 | - | -32.03 Thousand |
| Investments in PPE | -5727.00 | - | - |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | -32.03 Thousand |
| Financing Cash Flow | 2.35 Million | 1.17 Million | -1.62 Million |
| Debt repayment | -2.35 Million | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | - | - |
| Other Financing Activities | - | 1.17 Million | -1.62 Million |
| Accounts receivables | - | - | - |
| Accounts payables | - | - | - |
| Inventory | - | - | - |
| Other working capital | - | - | - |
| Cash at beginning of period | 1.33 Million | 1.75 Million | 4.81 Million |
| Cash at end of period | 733.18 Thousand | 1.33 Million | 1.75 Million |
| Capital Expenditure | -5727.00 | - | - |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -601.09 Thousand | -419.15 Thousand | -3.05 Million |
| Free Cash Flow | -2.95 Million | -1.59 Million | -1.39 Million |
2011
601717
WIN
AWEVF
WFC-PZ
NUVAMA